The read at a glance
Computed from the FY2026 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 4.04 — safe zoneOK
- Earnings-manipulation signal · Beneish M -2.52 — no flag raisedOK
- Earnings quality 86/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2026, as Prestige Consumer Healthcare Inc. reports it. History and quarterly detail are in the app.
- North American OTC Healthcare$913.6M
- International OTC Healthcare$175.1M
Leadership changes
From Prestige Consumer Healthcare Inc.'s own filings, the day they're filed.
- Christine Sacco · Chief Operating Officer · appointmenteff. 2025-01-06
- John F. Kelly · President · appointment
- John F. Kelly · Directors · departure
Latest filings
- 8-K · Company announcement2026-06-16
- 10-K · Annual report2026-05-14
- 8-K · Company announcement2026-05-13
- 8-K · Company announcement2026-03-20
- 8-K · Company announcement2026-02-05
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Prestige Consumer Healthcare Inc., every answer cited🔒
- The Intelligence Brief — added when Prestige Consumer Healthcare Inc.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.